Overcoming Challenges in Patient Referrals: Handling Reluctance and Navigating Barriers to Academic Care

Opinion
Video

Panelists discuss how multiple myeloma care faces challenges including patient reluctance to seek treatment at academic centers, complex treatment landscapes, and the need for improved coordination between community and academic physicians.

Video content above is prompted by the following:

  • What are some challenges are you currently seeing?
  • How do you handle cases where patients are reluctant to be referred to an academic center?
Recent Videos
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
4 experts in this video
4 experts in this video
Related Content